Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Aspiriant

RMEAX Expense Ratio & Fees

Ticker RMEAX · · Holdings as of Jun 30, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
+9.2%annualized
1-yr return
+17.7%as of Dec 2025
Net assets
$1.4Ball share classes
Holdings
144

Bottom line

What is RMEAX's expense ratio?

RMEAX's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is more expensive than 55% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load.

Updated Jul 29, 2026

RMEAX fee table

Net expense ratio0.95%
Gross expense ratio1.08%
Management fee0.24%
12b-1 (distribution) fee0%
Other expenses0.18%
Acquired fund fees0.66%
Fee waiver / reimbursement-0.13%
Max front-end sales load0%
Max deferred sales charge0%
Redemption fee0%

Source: Fund prospectus fee table, filed Jul 29, 2026

What RMEAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
RMEAX$97$331$583$1,305

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).

Cheapest way to own Aspiriant Risk-Managed Equity Allocation Fund

All share classes
TickerClassExpense ratioFront load
RMEAXAdvisor Shares0.95%0%
RMEIXInstitutional Shares1.2%0%